Home LiteratureArticle Details
PMID: 669854 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Reproductive factors and risk for breast cancer in Iceland.

International journal of cancer ·Vol. 21 ·No. 6 ·1978-06-15 ·Pages 724-30

Tulinius H, Day NE, Jóhannesson G, Bjarnason O, Gonzales M

Abstract

A previous publication has shown that there has been a great increase in the incidence of breast cancer in Iceland. The present study was undertaken to evaluate the importance of known risk factors connected with the reroductive history of the women. In a prospective investigation of a cohort of 31,453 women we confirmed previous findings of the increased risk following higher age at first pregnancy and for nulliparous women. The age at first pregnancy and the proportion of nulliparous women have decreased with time in the Icelandic population so that these factors should have tended to decrease the risk, making the found increase still more important. The effect of parity is that the risk decreases with larger number of children and this effect is independent of the effect of age at first pregnancy. Lower age at menarche increases the breast cancer risk, but the contribution of that factor to the overall risk is negligible.

MeSH Terms
Adult Age Factors Aged Breast Neoplasms/epidemiology Female Humans Iceland Maternal Age Menarche Middle Aged Parity Pregnancy Prospective Studies Risk
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Tulinius H
Day N E
Jóhannesson G
Bjarnason O
Gonzales M
Article Info
Journal
International journal of cancer
Abbr.
Int J Cancer
ISSN
0020-7136
Published
1978-06-15
Pages
724-30
Language
English
Region
United States
NLM ID
0042124
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com